1. Home
  2. GKOS vs WCT Comparison

GKOS vs WCT Comparison

Compare GKOS & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • WCT
  • Stock Information
  • Founded
  • GKOS 1998
  • WCT 2012
  • Country
  • GKOS United States
  • WCT Hong Kong
  • Employees
  • GKOS N/A
  • WCT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • WCT
  • Sector
  • GKOS Health Care
  • WCT
  • Exchange
  • GKOS Nasdaq
  • WCT NYSE
  • Market Cap
  • GKOS 5.1B
  • WCT 13.9M
  • IPO Year
  • GKOS 2015
  • WCT 2024
  • Fundamental
  • Price
  • GKOS $93.79
  • WCT $0.25
  • Analyst Decision
  • GKOS Strong Buy
  • WCT
  • Analyst Count
  • GKOS 13
  • WCT 0
  • Target Price
  • GKOS $155.00
  • WCT N/A
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • WCT 18.4M
  • Earning Date
  • GKOS 04-30-2025
  • WCT 12-07-2024
  • Dividend Yield
  • GKOS N/A
  • WCT N/A
  • EPS Growth
  • GKOS N/A
  • WCT N/A
  • EPS
  • GKOS N/A
  • WCT 0.05
  • Revenue
  • GKOS $383,481,000.00
  • WCT $2,370,163.00
  • Revenue This Year
  • GKOS $27.84
  • WCT N/A
  • Revenue Next Year
  • GKOS $27.99
  • WCT N/A
  • P/E Ratio
  • GKOS N/A
  • WCT $5.30
  • Revenue Growth
  • GKOS 21.85
  • WCT N/A
  • 52 Week Low
  • GKOS $77.91
  • WCT $0.12
  • 52 Week High
  • GKOS $163.71
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 46.82
  • WCT N/A
  • Support Level
  • GKOS $92.79
  • WCT N/A
  • Resistance Level
  • GKOS $97.38
  • WCT N/A
  • Average True Range (ATR)
  • GKOS 4.43
  • WCT 0.00
  • MACD
  • GKOS 1.61
  • WCT 0.00
  • Stochastic Oscillator
  • GKOS 72.39
  • WCT 0.00

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service (SaaS) platforms, and white-label software design and development services.

Share on Social Networks: